• Pivot developing nutraceutical and pharmaceutical therapies based on cannabis derivatives
• Female sexual dysfunction market expected to exceed booming male products market
• Skin and oral delivery of Pivot products driven by innovative technologies

The advent of modern licensing controls for over-the-counter medications in Canada nearly 15 years ago paved the way for people to pursue health options ranging from traditional Chinese medicines to manufactured vitamins with greater freedom. Caught up in the current were a number of cannabis-based therapies taking advantage of the growing attention paid to the plant’s medicinal properties. Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) is one of those companies, using the path to retail enabled by the Natural and Non-prescription Health Products Directorate in its effort to provide consumers with topical treatments for women’s sexual dysfunction and psoriasis, and an oral product for cancer supportive care, while, in the United States, its cannabinoid products anticipate wide availability through a state-by-state regulatory process.

Pivot Pharmaceuticals is an emerging biopharmaceutical company intent on using novel drug-delivery technologies to commercialize a variety of therapeutic pharmaceuticals and nutraceuticals, beginning with the three skin, cancer and sexual dysfunction products in development through agreements with Solmic GmbH (a privately / held German company) leveraging Pivot’s BiPhasix technology. Pivot’s technologies have shown a capacity for enhancing the bioavailability of the health products they carry while maintaining product stability (http://ibn.fm/EiXoN).

The success of erectile dysfunction product manufacture for men revealed a tableau of opportunities for pharmaceuticals treating time-of-life maladies that now are extending to women’s health as well. Men’s products have resulted in a $3 billion-plus market, but researchers estimate a larger potential market exists for women (http://ibn.fm/EaRAz) with the likelihood of a $7.7 billion combined market by 2019 (http://ibn.fm/lESlg). Pivot’s cannabidiol (CBD) product targets a decline in sexual desire and response in perimenopausal, menopausal and post-menopausal women through an applicable cream.

Cancer patients troubled by nausea, vomiting, mucositis, neutropenia and anemia — a reported 70 to 80 percent of those undergoing chemotherapy (http://ibn.fm/f7MJM) — are already finding Pivot’s therapeutic natural product treatment in Europe. Grand View Research’s forecasts anticipate a $29.87 billion cancer supportive care products market by 2021, and preclinical research into the anti-inflammatory benefits of cannabis are driving product development for treating dry, itchy skin ailments such as psoriasis and eczema. Statista predicts that the global skin disease care market will grow to $20.4 billion by 2020, with $8.6 billion of that coming from the United States (http://ibn.fm/oDhIi).

Pivot anticipates that the natural health product regulatory pipeline, such as that envisioned by Canada’s NNHPD, will help get its products into consumers’ hands more quickly than extended pharmaceutical trials and ,in so doing, will ultimately accomplish the products’ purpose of providing relief to the masses. Pivot’s medical cannabis product division, Pivot Green Stream Health Solutions (PGS), is responsible for taking products from research through commercialization, both in the nutraceutical and the pharmaceutical pipelines, involving not only CBD but also products derived from its more regulated tetrahydrocannabinol (THC) sibling. Other products anticipated for development will target pain, inflammation and eye disease.

For more information, visit the company’s website at www.PivotPharma.com

• Cryptocurrencies gain in acceptance, but…
• High transaction fees and lengthy processing times delay implementation
• Bit4Sure cuts bitcoin transaction times

Now that some marquee names – Microsoft, Expedia, Overstock – have begun accepting bitcoin, it looks as if cryptocurrencies have entered the mainstream of commerce. Notice from Japanese retailer Rakuten appears to confirm that. The ecommerce giant, which has been called Japan’s Amazon, has announced plans to launch its own “Rakuten Coin” in the near future (http://ibn.fm/ld2I7). Not so fast, however. Ironically, Satoshi Nakamoto’s peer-to-peer payment system, which held out the promise of no intermediaries charging transaction costs, is plagued by high transaction costs. Other frictions also exist, one of which is tardy speed of execution. Nevertheless, getting bitcoin payments up to speed may be just around the corner.

Virtual Crypto Technologies Inc. (OTCQB: VRCP) has launched Bit4Sure, a proprietary cryptocurrency transaction confirmation solution. Virtual Crypto Technologies is a technology company dedicated to making cryptocurrencies accessible to the public, specifically by creating payment solutions for businesses and consumers, which combine application programming interfaces and mobile applications for implementation across ATMs, PCs, tablets and other mobile devices.

As useful as blockchain technology is turning out to be, its employment in payment transactions is running into unanticipated problems that result in high transaction fees and delayed processing. One major issue with blockchain processing is the limit on the number of transactions that can be “confirmed” in each block and the time it may take to “fully” verify a transaction. Authenticating a bitcoin transaction can be quite lengthy because of the confirmation steps involved.

The process begins when a bitcoin payment is made, an event that broadcasts to the bitcoin network that the transaction is now in the “unconfirmed transactions” pool. Bitcoin miners will access this unconfirmed transactions pool and attempt to verify the transactions they find there by solving complex algorithms. If they do, they group the transactions into a “block”, which is set at the end of the existing blockchain, extending it. Every time a new block is verified, the older, existing blocks are re-verified. Thus, older blocks carry more trust than newer ones. However, this going over old ground can drag out transaction time. Moreover, only a limited number of transactions can be confirmed in one block, which means that, typically, a new bitcoin block only appears after about 10 minutes.

Sometimes (especially when the price spikes), bitcoin transactions surge, resulting in increased competition for limited block space; this drives up fees. Bitcoin fees are computed according to system rules that take into account the coins someone plans to spend, their size, their age, and the transaction size. The bitcoin system does not add coins; every coin is kept separately in a wallet. When a payment is made, the wallet will attempt to select coins to match the amount. It’s very similar to paying $0.65 with traditional coins, where a consumer could select two quarters, a dime and a nickel. This increases transaction size and fees. If, instead, a user were making a 0.65-bitcoin payment and happened to have a 0.65 bitcoin, transaction size and fees, and possibly time as well, would be less.

Fortunately, the Virtual Crypto Bit4Sure solution is sure to cut transaction time (http://ibn.fm/b3yoM). It bridges the time gap from when a transaction is published on the bitcoin network to the moment it joins the blockchain, essentially confirming a transaction before it reaches the blockchain for inclusion in a mined block. The Bit4Sure API also provides subscribers with direct access to Virtual Crypto’s proprietary algorithm model, giving them real-time confirmation of cryptocurrency transactions, as well as the ability to monitor the trading market of any cryptocurrency, protecting subscribers from delay, double spending and fraud. Virtual Crypto anticipates that the Bit4Sure API will be particularly attractive to crypto exchanges, payment processors, crypto wallets and other direct participants in the industry. The platform incorporates a mobile app for consumers.

For more information, visit the company’s website at www.Virtual-Crypto.com

• Cobalt is a critical element in lithium-ion batteries, which power electric vehicles, smartphones and laptops
• First Cobalt assay results indicate doubled strike length of newly identified mineralized zone in Canadian Cobalt Camp
• Exploration of cobalt production to accelerate following acquisition of U.S. Cobalt property in Idaho
• Cobalt market reached $8 billion in 2016, with global sales of electric vehicles rising by 63 percent in 2017

First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) is strategically positioning itself as a leading pure-play cobalt exploration and development company as it continues to add historical mineral resource properties to its portfolio. The previously announced acquisition of U.S. Cobalt is poised to expand the company’s assets into Idaho at the Iron Creek Project, which includes a substantial amount of previous exploratory work. This project, located along the most prolific trend of cobalt mineralization in the United States along the Idaho Cobalt Belt, has an historic mineral resource estimate (non-compliant with NI 43-101) of 1.3 million tons grading 0.59 percent cobalt, and shareholders were encouraged to support the proposed acquisition (http://ibn.fm/4qEiv).

Overall, the deal adds U.S. Cobalt’s exploration properties in Idaho and Utah to First Cobalt’s 50 mining properties in Cobalt, Ontario, Canada, which also include the only permitted cobalt refinery in North America capable of producing battery materials. Dr. Frank Santaguida, P.Geo., First Cobalt’s vice president, exploration, spoke to Reuters at a Canadian mining conference in London about the company’s push to increase its holdings and develop its resources.

“A pipeline of projects is what’s necessary to really move forward and to continually assess the best things to develop,” Santaguida said in an article published by Reuters on April 25, 2018 (http://ibn.fm/MycuN). “Cobalt demand is now. Predictions are it will last for about 10 years at least, so it is about getting to that early production.”

The booming demand for cobalt is closely tied to the rapidly developing lithium-ion battery market, which depends on cobalt as a critical element. The fastest growing segment of this battery market is the electric vehicle or EV industry. Legislation enacted in leading European countries and China promises to do away with the standard gas and diesel-powered vehicles and replace them with electric vehicles. By 2025, about 14 percent of all cars sold in the world will run on battery power, with a solid third of the vehicles sold in Europe powered by rechargeable batteries, according to an article in Mining-Technology.com (http://ibn.fm/piaP7).

First Cobalt announced on May 3 that results of recent drilling in the Kerr Area, located within the company’s Canadian Cobalt Camp property, have doubled the strike length of the mineralized zone to over 200 meters, making it a prime target for further exploration, Trent Mell, President and CEO, said in a news release (http://ibn.fm/hrXAW).

“Our 2018 drilling program will continue targeting 15 areas containing past-producing mines,” added Mell. “But the Kerr area is now a high priority for exploration work.”

First Cobalt’s determination to be a leading conflict-free, cobalt company is ingrained in the company culture, unlike many of the mining operations in the Democratic Republic of Congo that utilize child labor in a politically unstable region. First Cobalt adopted the Responsible Cobalt Initiative in 2017 that calls on companies to trace how their cobalt is extracted, transported, manufactured and sold. The company’s guiding principle is “zero harm” to people, the environment and the communities in which it operates, providing a common link to the green goals enshrined in the electric vehicle revolution.

For more information, visit the company’s website at http://ibn.fm/FTSSF

• Total number of electric vehicles on the road may reach 40 million globally by 2025
• One electric vehicle uses more lithium in its batteries than 10,000 smartphones
• High-grade assays at Irgon Mine signal project feasibility

The scramble for lithium continues, fueled by promising projections like those issued by the International Energy Agency (IEA). In a revealing analysis on the global electric vehicle industry, the agency estimates that the global stock of electric cars will rise to 40-70 million by 2025 (http://ibn.fm/jNUDT). In 2016, the number of electric cars on roads around the world surpassed two million, after crossing the one million mark in 2015. Those numbers signal voracious future demand for lithium, far exceeding that required at present for smartphone manufacture, since, for example, ‘a Tesla Model S uses more lithium in its batteries than 10,000 smartphones’ (http://ibn.fm/UuB12). Thus, although a huge rise in output is forthcoming from the Lithium Triangle – Argentina, Bolivia and Chile – market supply may still fall short of that required by global battery makers. Such market factors favor junior exploration company QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ). The corporation, based in Vancouver, British Columbia, is mining for lithium at Cat Lake, a property that hosts several rare-element granitic pegmatite occurrences, including the one at the Irgon Lithium Mine Project.

The Irgon Lithium Mine Project, located immediately north of Cat Lake, Manitoba, is home to pegmatite rich in cesium (CS), tantalum (Ta) and lithium (Li). The former owner of the property, the Lithium Corporation of Canada Limited, carried out substantial developmental work, and the deposit is estimated to contain more than 1.2 million tonnes of spodumene-bearing pegmatite graded at 1.5 percent lithium oxide. Overall, the Irgon property comprises the Irgon occurrence and several other known pegmatite dikes on 13 adjoining mineral claims covering 6,538 acres.

QMC’s portfolio also includes two volcanic massive sulphide (VMS) properties – the Rocky Lake and Rocky-Namew, known collectively as the Namew Lake District Project – which contain base metal-rich mineral deposits. These claims extend over approximately 23,000 hectares (~57,000 acres) in one of Canada’s most productive mining regions – the Flin Flon/Snow Lake VMS mining district of Manitoba, Canada.

QMC recently announced the release of results of historical assays conducted by the Lithium Corporation of Canada (LCOC) (http://ibn.fm/o6eUM). These historical assays – 2.3 percent lithium oxide over 7.3 feet – were obtained during LCOC’s 1956 channel sampling of the Irgon Dike where it is exposed underground in crosscuts on the 200-foot level. Models of these underground workings demonstrate that, to date, exploration and underground development have only been undertaken on the upper and central portions of dike, leaving significant potential to quickly increase tonnage as the Irgon Dike is open both along strike and to depth. The 2.3 percent lithium oxide assays put the deposits in the high-grade class, commercially feasible at present lithium prices.

This promising prognosis has cheered QMC’s experienced leadership team, which includes specialists in mineral exploration, geology, engineering, new business development, marketing and investor relations. The team includes consultant Bruce E. Goad, P. Geo., who has 40 years of experience in mineral exploration in Canada, Argentina, Asia and Africa. As a Qualified Person, Goad has worked on numerous deposit styles including rare element bearing pegmatites (Li, Ta, Nb, Be, Sn, U, TH), porphyries, banded iron formation (BIF) gold deposits, skarn, greisens and VMS. He has a wide and varied skillset which includes precious, base, industrial and rare metal projects with a sharp focus on gold exploration. Goad is the author of several scholarly publications on pegmatite granites of the southeastern Manitoba region.

For more information, visit the company’s website at www.QMCMinerals.com

• Focused on growing strategic portfolio of industrial hemp-based companies
• Entered into joint venture with Marijuana Company of America, Inc. to purchase 109-acre farm in Oregon for cultivation of legal, high-yielding CBD from industrial hemp
• Hemp industry projected to reap $1.8 billion in sales by 2020, with growing political support
• 2018 growing season includes commercial hemp development projects at farms in Canada and Oregon

Hemp cultivation company Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) continues to execute its strategic growth plan with the recent purchase of 109 acres of prime agricultural land in Oregon with joint venture partner Marijuana Company of America (OTC: MCOA). The company-partners plan to cultivate legal, high-yielding CBD (cannabidiol) industrial hemp to be grown at the farm located near the 152-year-old, picturesque town of Scio, Oregon (http://ibn.fm/mAhXa).

Industrial hemp is an agricultural heritage plant with a rich history. It also enjoys increasing political support, avoiding the legal challenges still faced by cannabis. Today’s hemp industry trumpets a variety of valuable niche markets, including personal care, hemp-derived cannabidiol (CBD) products, superfoods, supplements, textiles, industrial applications, building materials and pet care/health and wellness products. To qualify as industrial hemp, regulations in the United States and Canada require less than 0.3 percent Delta 9 Tetrahydrocannabinol (THC) content, the psychoactive ingredient in cannabis.

Hemp Business Journal, a leading provider of data and market intelligence for the hemp industry, estimates that sales of hemp CBD-based products are the fastest growing segment of the hemp market, rolling in with $130 million in sales and growing at a 53 percent annual growth rate in 2016. Looking forward, data suggests that the hemp industry will grow to $1.8 billion in sales by 2020, the Hemp Business Journal reports (http://ibn.fm/g8FNR).

Global Hemp Group and MCOA first entered into a joint venture for hemp research in 2017 at a similarly sized farm on the Acadian Peninsula of New Brunswick, Canada. Following a successful first year of cultivation trials, the partners are now moving forward with commercial industrial hemp production with the end goal of extracting several different cannabinoids to provide near-term revenue. Experienced hemp farmers are already on board to grow hemp on the New Brunswick property in 2018, with plans to cultivate more than 1,000 acres by year three. This joint venture relationship has evolved further with the acquisition of 109 acres and a JV agreement for the Scio, Oregon, project.

Global Hemp Group developed the unique concept of a Hemp Agro-Industrial Zone (HAIZ) for the purpose of building cooperative mechanisms across industrial sectors that focus on different parts of the hemp plant. Under the HAIZ strategy, Global Hemp Group brings together capital, farmers and labor in an effort to build a “soil-to-shelf” portfolio of complimentary companies and joint venture partners in the global hemp industry (GlobalHempGroup/HAIZ).

As a publicly traded company headquartered in British Columbia, Canada, Global Hemp Group is focused on attracting joint venture partners across all sectors of the industrial hemp industries with a commitment to improving quality of life by researching, developing and distributing sustainable materials, products and services produced from hemp and, at the same time, consistently delivering a positive return on investment to shareholders.

For more information, visit the company’s website at GlobalHempGroup.com

• Focus is on investing in and building vertically integrated portfolio in wholesale/retail, distribution and nutraceutical cannabis products for pets through legal cannabis ventures in North America
• Holdings include North Road Ventures, an emerging distributor of cultivated and manufactured cannabis products and holder of a pending ACMPR application for a license amendment to sell, distribute cannabis and related products
• Distribution strategy involves end-to-end, full cycle wholesale delivery

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P), a vertically integrated cannabis company with strategic investments, continues its push to be ready for the green rush coming to Canada’s cannabis consumers. According to Statista, the medical marijuana market in Canada is projected to be worth C$1.1 billion in 2020 (http://ibn.fm/j1jGC). Canadian lawmakers are poised to open the adult-use recreational cannabis market by the fall of 2018, which is expected to make the nation’s combined medical/recreational cannabis market worth about $2.8 billion by 2020 (new CIBC report states that the market for Canadian adult use cannabis will approach $6.5 billion in retail sales by 2020) (http://ibn.fm/p8iCL).

Liberty Leaf and its wholly owned subsidiary, North Road Ventures, recently signed an agreement with Cannabis Compliance Inc. (“CCI”) to establish Good Manufacturing Practice (GMP)-compliant processes and procedures for producing its finished products (http://ibn.fm/GsomZ). North Road has an application pending with Health Canada for an Access to Cannabis for Medical Purposes Regulations (ACMPR) license to distribute up to 7,500 kilos (16,500 pounds) of cannabis in its first year of operation.

Liberty Leaf expanded its portfolio in 2017 when it signed an agreement to develop up to four proprietary cannabidiol (“CBD”) formulations with ESEV Genetics R&D LLC, an American life sciences company researching cannabis and its role in medical solutions (http://ibn.fm/zPoWP). Together, Liberty Leaf and ESEV are working on a potentially very lucrative market – health and wellness for pets, specifically focusing on the efficacy of CBD pain management for canine osteoarthritis.

Liberty Leaf’s commitment to invest strategically in up-and-coming and established companies in the medicinal and recreational cannabis space is not relegated to Canada. The company is actively seeking to enter the various legal cannabis markets in North America, which Statista reports will bloom to more than $16 billion by 2020 (http://ibn.fm/EBWqV).  A recent Deloitte report estimates that legal weed could be a $22.6 billion industry in Canada alone (http://ibn.fm/HXOln).

Liberty Leaf provides funding, management, HR resources and marketing expertise to help its investment holdings thrive and accelerate growth. Working relationships are formed with organizations engaged in research and development of cannabis uses, which also helps Liberty Leaf in its mission to expand and develop new markets.

For more information, visit the company’s website at www.LibLeaf.com

• Mobile gaming apps approaching 50 percent of total gaming market
• Mobile gaming surpassed $50 billion mark during 2017
• Consorteum’s Universal Mobile Interface supports flexible data usage in variety of vertical markets

The enactment of the European Union’s first cybersecurity law on May 9 (http://ibn.fm/flj1x) and the ongoing European Commission discussion about its pending cybersecurity act serve as the latest reminders about the global nature of modern telecommunications connectivity and consumers’ need to protect their data while striving to benefit from the availability of data worldwide. Corporate players in the mobile connectivity arena such as Consorteum Holdings, Inc. (OTC: CSRH) find themselves tasked with helping their clients bridge divides between data providers across a spectrum of languages and cultures while striving to keep uninvited guests at a distance.

Such business needs are the sobering part of providing marketable products for consumers who in most cases are looking for ways to make their lives more enjoyable. Consorteum Holdings and its 359 Mobile, Inc. subsidiary are specifically focused on developing and delivering end-to-end solutions for players in the fintech and data analytics industries, but the companies’ first app to market is an entertaining sports analytics product that gives cricket fans solid information on team and/or specific players’ performance and their potential.

Earlier this month, Consorteum announced that it had advanced development of its Edgelytics™ predictive analytics mobile app past focus group research and toward launch (http://ibn.fm/4UDL1). The first Edgelytics™ product will be an app to help sports betting fans of cricket, the second most popular sport in the world behind soccer. It is expected to be available this summer on all Android and iOS devices. The app will mine historical statistics and provide artificial intelligence to help predict probable future performance of the athletes involved.

Mobile devices accounted for nearly half the total gaming market following a period of noteworthy growth in 2017 (http://ibn.fm/Dh6s1). As a trend, it is becoming especially popular in Europe and the United Kingdom, hence the attention to sports such as cricket. Worldwide, mobile gaming was responsible for an estimated $50 billion in revenues last year (http://ibn.fm/cMWpK).

“Exactly 10 years ago, the launch of the iPhone ignited a revolution in games, creating a new market segment,” a recent Newzoo article states (http://ibn.fm/FbhOS). “The past years have seen the rise of esports, taking the already popular activity of viewing game video content to a professional level. … Underlying this success are the tools given to consumers to create and share their own experiences around their favorite game franchises.”

While many mobile applications are beset by limitations on how users can interact or the number of devices they can support, Consorteum’s key product, its Universal Mobile Interface™ (UMI) is a state-of-the-art platform built to integrate any stream of data onto a mobile platform.

The UMI aims to create open-sky opportunities for strengthening business verticals, particularly areas such as fintech management, digital marketing, data storage, cloud utilization, analytics, customer relations management, secure payment processing and compliance with regulatory codes (http://ibn.fm/SKxnn).

For more information, visit the company’s website at www.Consorteum.com

• CBD segment projected to grow to $2.1 billion by 2020
• Global hemp-based foods market forecast to grow at a CAGR of 24 percent from 2018 to 2022
• ETST uses cutting-edge technology to produce the highest-grade full spectrum hemp oil for product formulation

The CBD segment is one of the main drivers of the huge growth in the cannabis industry, with the Hemp Business Journal projecting this segment to grow to $2.1 billion by 2020 (http://ibn.fm/Tg8C7). In addition, market research analysts Technavio forecast that the global hemp-based foods market will grow at a CAGR of over 24 percent through 2021 (http://ibn.fm/PhzCm). Earth Science Tech, Inc. (OTC: ETST) is an innovative biotech company with a primary focus on delivering high grade hemp-derived, cannabidiol (CBD)-based products to this market. It has a further focus on the development of diagnostic tools, testing processes and medical devices.

The company uses the latest supercritical CO2 cold liquid extraction method to produce the highest quality and purity full spectrum hemp oil, which is neither synthetic nor an isolate. ETST’s range of high grade cannabinoids extracted during this process contain a variety of valuable phyto-nutrients, essential oils and other naturally occurring therapeutic compounds found in the hemp plant. These are used to develop and commercialize products for the pharmaceutical and nutraceutical markets.

The company is the top brand for nutritional and dietary supplements in the industrial hemp market. ETST’s high grade CBD-rich hemp oil is classified as “food based” and is permissible in all 50 U.S. states and around 40 countries. It is used in the formulation of a wide range of CBD-infused products, including vitamins, minerals, herbs, botanicals, homeopathies, personal care products and functional foods. The company delivers its products in a variety of forms, such as capsules, soft gels, tablets, chewables, liquids, creams, sprays and powders.

ETST operates through several wholly owned subsidiaries:

• Cannabis Therapeutics, Inc. is an emerging biotechnology company that’s poised to become a world leader in cannabinoid research and development for a broad line of cannabis and cannabinoid-based pharmaceuticals and nutraceuticals, as well as other products and solutions.
• Earth Science Pharmaceutical, Inc. is focused on becoming a world leader in the development of low cost, non-invasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections (STIs) and diseases (STDs).
• KannaBidioid, Inc. is focused on the manufacture and distribution of vapes/e-liquids and gummy edibles in the recreational space, formulated using its unique Kanna and CBD formula.

In addition, the company established a Canadian subsidiary, Canna Inno Laboratories Inc., in 2017 to give it a foothold in the Canadian cannabis market. Based in Montreal, Quebec, Canna Inno received a grant from the Government of Quebec in March 2018 to fund its innovation drive in the pharmaceutical industry. This grant will be used for the pre-launch of three of ETST’s CBD-based patented nutraceutical products to fight breast cancer and neurodegenerative disorders. The company plans to apply for more grants under the Canadian government’s Scientific Research and Experimental Development Tax Credit program.

ETST has listed several of its products for sale on its website, including raw and flavored High Grade Hemp CBD Oil tinctures, CBD veggie capsules and e-liquids in six flavors. Customers can purchase single and bulk tinctures, bulk wholesale oil, powder, vape oil and other formulations for health and wellness.

For more information, visit the company’s website at www.EarthScienceTech.com

• Changing the status quo in the energy industry by reducing utility expenses through its cutting edge Zero Cost Program
• Joshua Campbell elected to the board of directors
• Chris Crabtree is a new key addition to the executive leadership team

Zenergy Brands Inc. (OTC: ZNGY), the nation’s leading next-generation energy and technology company, recently announced the election of Joshua Campbell to its board of directors and the addition of Chris Crabtree to the executive leadership team. The company aims to increase the enterprise value and bottom line of life-long clients while significantly reducing the carbon footprint in the United States, as well as the demand on the national energy grid and water supply.

Through its cutting edge Zero Cost Program, ZNGY specializes in reducing electricity, natural gas and water consumption by as much as 20-60 percent. The real-time impact of the company’s sustainability projects can be found at www.ZenergyBrands.com. To date, these programs have helped avoid over 13.7 million pounds of carbon dioxide emissions, saved roughly 1.2 million gallons of water and prevented the use of 700,213 gallons of gas. In addition to the positive environmental impact, they have created significant savings for Zenergy’s customers.

Joshua Campbell, newly elected to the board of directors, has served the company as the senior vice president of operations since joining in mid-2017. He will be transitioning into his new role and title of senior vice president of administration & planning. “It is truly an honor and a privilege to have been elected to Zenergy’s Board of Directors, a development I am humbled by and grateful for,” Campbell stated following the appointment.

Chris Crabtree will be assuming Campbell’s previous position as senior vice president of operations, effective June 1. Crabtree’s 22 years of business experience and 17 years of energy industry experience make him a perfect fit for this key position on the executive leadership team. “I am delighted by the opportunity to join Zenergy’s executive leadership team of industry veterans. I have been following the company closely since its inception and have been encouraged by the progress they have made,” said Crabtree. “I can hardly wait to roll up my sleeves and apply my work ethic and contribute my expertise to help fulfill Zenergy’s objectives.”

Both Campbell and Crabtree are eager to put their experience to work toward fulfilling the company’s mission to be the nation’s leading next-generation utility (http://ibn.fm/0suvB).

For more information, visit the company’s website at www.ZenergyBrands.com

• Report: LXRP is a ‘compelling investment opportunity’ which is creating recurring licensing revenue that unlocks shareholder value
• LXRP’s DehydraTECH is a patented delivery technology platform that is renewal-licensed by Nuka in a 10-year semi-exclusive agreement that expands its reach into Canada
• Company is growing its patent portfolio for proprietary DehydraTECH; it already has patents granted in Australia and the U.S. and has patents pending in more than 40 countries worldwide

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) renewal of its DehydraTECH™ license with Nuka Enterprises LLC could help make it a compelling investment opportunity in the cannabis industry as its licensing and royalties from that technology platform deliver recurring revenue that could unlock significant value for its shareholders, according to an article by CFN Media Group (http://ibn.fm/StgYG).

Chris Bunka, CEO of LXRP, estimated in an audio interview that up to 80 percent of Lexaria’s revenues are generated through the licensing of its proprietary technology to other companies (http://ibn.fm/U0L7n). CFN wrote that the Nuka license renewal “represents a strong vote of confidence in the technology.”

LXRP is a British Columbia, Canada-based bioscience company that is a drug delivery platform innovator. It out-licenses its disruptive delivery technology that promotes healthier ingestion methods and lower overall dosing. It has developed the patented DehydraTECH delivery technology platform.

Nuka Enterprises markets the 1906 brand of cannabis chocolates using LXRP’s technology. It has been using LXRP’s platform for almost two years, when it first entered the cannabis market. The renewal enables Nuka to market across the U.S. It also has an option that permits the company to expand into Canada with the brand through the use of LXRP’s existing contract manufacturer of chocolates and confections licensee, Cannfections Group Inc. (http://ibn.fm/bBOuC).

Nuka has indicated that it will initially focus on the U.S. states that permit recreational and adult-use of cannabis, such as Colorado, Nevada, California, New Jersey and Massachusetts. Bunka said that LXRP believes that 6-12 more licensing contracts will be signed this year, generating more revenue for the company and building greater shareholder value.

For more information, visit the company’s website at www.LexariaBioscience.com